|
Re: RESVERLOGIX ANNOUNCES PROPOSED OFFERING OF UNITS April 17, 2018
|
4
|
Resverlogix Corp.
|
May 14, 2019 10:58PM
|
|
Re: Updated fact sheet
|
4
|
Resverlogix Corp.
|
Nov 06, 2020 12:23PM
|
|
Bioasis Announces Publication of CNS Delivery of siRNA via xB³ ™ Platform Technology
|
4
|
BIOASIS TECHNOLOGIES INC
|
Mar 29, 2021 04:11PM
|
|
Financials are out
|
4
|
Resverlogix Corp.
|
Jul 30, 2018 08:41PM
|
|
Re: Why is pps where it is
|
4
|
Resverlogix Corp.
|
Feb 23, 2020 05:02PM
|
|
Re: Funny side point
|
4
|
Resverlogix Corp.
|
Sep 01, 2015 04:52PM
|
|
Re: Late Breaker program?
|
4
|
Resverlogix Corp.
|
Mar 22, 2020 10:43PM
|
|
Re: Bioasis Announces Filing of Its Quarter and Financial Statements and MD&A for the Period Ending November 30, 2020
|
4
|
BIOASIS TECHNOLOGIES INC
|
Jan 28, 2021 07:38AM
|
|
Re: Late Breaker program?
|
4
|
Resverlogix Corp.
|
Mar 22, 2020 11:07PM
|
|
Re: AHA 2020
|
4
|
Resverlogix Corp.
|
Sep 17, 2020 01:40PM
|
|
Re: Apabetalone publication in "Current Opinion in Nephrology & Hypertension"
|
4
|
Resverlogix Corp.
|
Jan 30, 2020 10:29AM
|
|
It’s Time to Go Deeper with Bioasis
|
4
|
BIOASIS TECHNOLOGIES INC
|
Aug 11, 2021 08:57AM
|
|
Re: Playing with Number of patient years and RRR%
|
4
|
Resverlogix Corp.
|
Apr 04, 2019 03:00PM
|
|
Resverlogix Announces Corporate Update Conference Call & Webcast on June 10, 2020 and Upcoming Presentation at the 57th ERA-EDTA Virtual Congress on
|
4
|
Resverlogix Corp.
|
Jun 05, 2020 07:03PM
|
|
BETonMACE CKD substudy abstract was supposed to be posted in AJKD
|
4
|
Resverlogix Corp.
|
Mar 26, 2020 08:47PM
|
|
Re: GV on stock house
|
4
|
Resverlogix Corp.
|
Apr 08, 2021 01:37PM
|
|
Re: Rules of thumb and broken thumbs...
|
4
|
Resverlogix Corp.
|
Sep 29, 2020 09:42AM
|
|
Re: Resverlogix is hopefully applying for governmental fund for MACE in Covid-19
|
4
|
Resverlogix Corp.
|
May 10, 2020 07:14PM
|
|
Re: Irrational exuberance
|
4
|
Resverlogix Corp.
|
Sep 17, 2020 07:01PM
|
|
Re: From the NKF Facebook Page...
|
4
|
Resverlogix Corp.
|
Feb 26, 2020 01:33PM
|
